Company
Predicta
Unlocking Molecular Insights for Blood Cancer Care
Also known as Predicta Biosciences, Predicta Biosciences, Inc.
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- Founded
- 2023
- Customers
- clinicians, researchers, and pharmaceutical partners
- Legal name
- Predicta Biosciences, Inc.
- predictabiosciences.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Using molecular diagnostics to transform the patient experience and unlock novel therapies.
Funding snapshot
- Total raised
- $28.6MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $23.4M2025-10-01
Funding rounds
- Round, 2025
- $23.4M2025-10-01, Company stated
- Round, 2024
- $5.2M2024-07-16, Company stated
Products
- Other
- GenoPredicta
- Web
- GenoPredicta
- Other
- ImmunoPredicta
- Web
- ImmunoPredicta
Loading relationship preview